Filter Results :

Your search for Immune returned 143 reports

Sort by


Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape. The report provides comprehensive information on the therap...

$ 2,000.00

Read More

Global Autoimmune Drugs Market 2016-2020

18 Mar 2016  |  Published by:  Technavio
About Autoimmune Diseases Drugs Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous syst...

$ 2,500.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura). The main objective of this report to track competitor pipelin...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The rep...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the unders...

$ 2,000.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the re...

$ 2,000.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The main objective of this report to track competitor pipel...

$ 1,250.00

Read More

Primary Immune Deficiency (PID)-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Primary Immune Deficiency (PID)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Primary Immune Deficiency (PID). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2014

01 Jan 2016  |  Published by:  DelveInsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of t...

$ 1,250.00

Read More

Global Autoimmune Treatment Industry 2015 Market Research Report

18 Dec 2015  |  Published by:  9Dimen Research
2015 Global Autoimmune Treatment Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Autoimmune Treatment industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan an...

$ 2,850.00

Read More

Immune Response BioPharma, Inc. - Product Pipeline Review - 2015

16 Dec 2015  |  Published by:  Global Markets Direct
Summary‘Immune Response BioPharma, Inc. - Product Pipeline Review - 2015’, provides an overview of the Immune Response BioPharma, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Response B...

$ 1,500.00

Read More

Immunetics, Inc. - Product Pipeline Analysis

09 Dec 2015  |  Published by:  GlobalData
SummaryImmunetics, Inc. (Immunetics) is a diagnostic company that research and develops assay technology for blood screening and infectious disease diagnosis. The company’s products include diagnostic tests, blood screening and blotting instruments. It has developes and markets tests based on ELISA ...

$ 750.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2015

30 Nov 2015  |  Published by:  Global Markets Direct
Summary‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2015’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic develo...

$ 2,000.00

Read More

Applied Immune Technologies Ltd - Product Pipeline Review - 2015

30 Nov 2015  |  Published by:  Global Markets Direct
Summary‘Applied Immune Technologies Ltd - Product Pipeline Review - 2015’, provides an overview of the Applied Immune Technologies Ltd’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Applied Immune Te...

$ 1,500.00

Read More
Total 143 records.